| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10063594 | The Breast | 2018 | 28 Pages |
Abstract
Among breast cancer patients treated with BCS, the luminal B/HER2-negative subtype predicts an about 3-fold higher risk for IBTR compared to other intrinsic subtypes independent of postoperative radiation therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Ã
sa Wickberg, Anders Magnuson, Lars Holmberg, Hans-Olov Adami, Göran Liljegren,